| pubmed-article:6189503 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6189503 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:6189503 | lifeskim:mentions | umls-concept:C0005149 | lld:lifeskim |
| pubmed-article:6189503 | lifeskim:mentions | umls-concept:C0002520 | lld:lifeskim |
| pubmed-article:6189503 | lifeskim:mentions | umls-concept:C0007737 | lld:lifeskim |
| pubmed-article:6189503 | lifeskim:mentions | umls-concept:C0041980 | lld:lifeskim |
| pubmed-article:6189503 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:6189503 | lifeskim:mentions | umls-concept:C0332208 | lld:lifeskim |
| pubmed-article:6189503 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:6189503 | pubmed:dateCreated | 1983-7-29 | lld:pubmed |
| pubmed-article:6189503 | pubmed:abstractText | Cephapirin, a beta-lactam antibiotic, was administered intravenously to five healthy subjects in a dose of 1 g. Renal clearances of cephapirin, beta 2-microglobulin, uric acid and amino acids were measured during the experiment and compared to timed control data, i.e. when no cephapirin was given. Renal clearance of cephapirin decreased when plasma concentrations declined. As protein binding of cephapirin is constant over a wide plasma concentration range, this finding may indicate that cephapirin is reabsorbed in the kidney by a saturable process. Renal clearance of endogenous amino acids, particularly those belonging to the basic group increased after cephapirin. There was no change in renal clearance of beta 2-microglobulin which excludes a general toxic effect on tubular reabsorption of endogenous substances caused by cephapirin. A flow dependent increase of uric acid clearance was observed. Our results are suggestive of a competition between cephapirin and amino acids for some common step in the tubular reabsorption process. | lld:pubmed |
| pubmed-article:6189503 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6189503 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6189503 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6189503 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6189503 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6189503 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6189503 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6189503 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6189503 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6189503 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6189503 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6189503 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6189503 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6189503 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6189503 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6189503 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6189503 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6189503 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6189503 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6189503 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:6189503 | pubmed:issn | 0306-5251 | lld:pubmed |
| pubmed-article:6189503 | pubmed:author | pubmed-author:ArvidssonAA | lld:pubmed |
| pubmed-article:6189503 | pubmed:author | pubmed-author:AlvánGG | lld:pubmed |
| pubmed-article:6189503 | pubmed:author | pubmed-author:BorgåOO | lld:pubmed |
| pubmed-article:6189503 | pubmed:author | pubmed-author:EklöfRR | lld:pubmed |
| pubmed-article:6189503 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6189503 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:6189503 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6189503 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6189503 | pubmed:pagination | 339-46 | lld:pubmed |
| pubmed-article:6189503 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:6189503 | pubmed:meshHeading | pubmed-meshheading:6189503-... | lld:pubmed |
| pubmed-article:6189503 | pubmed:meshHeading | pubmed-meshheading:6189503-... | lld:pubmed |
| pubmed-article:6189503 | pubmed:meshHeading | pubmed-meshheading:6189503-... | lld:pubmed |
| pubmed-article:6189503 | pubmed:meshHeading | pubmed-meshheading:6189503-... | lld:pubmed |
| pubmed-article:6189503 | pubmed:meshHeading | pubmed-meshheading:6189503-... | lld:pubmed |
| pubmed-article:6189503 | pubmed:meshHeading | pubmed-meshheading:6189503-... | lld:pubmed |
| pubmed-article:6189503 | pubmed:meshHeading | pubmed-meshheading:6189503-... | lld:pubmed |
| pubmed-article:6189503 | pubmed:meshHeading | pubmed-meshheading:6189503-... | lld:pubmed |
| pubmed-article:6189503 | pubmed:meshHeading | pubmed-meshheading:6189503-... | lld:pubmed |
| pubmed-article:6189503 | pubmed:meshHeading | pubmed-meshheading:6189503-... | lld:pubmed |
| pubmed-article:6189503 | pubmed:meshHeading | pubmed-meshheading:6189503-... | lld:pubmed |
| pubmed-article:6189503 | pubmed:year | 1983 | lld:pubmed |
| pubmed-article:6189503 | pubmed:articleTitle | Effect of cephapirin on tubular reabsorption of amino acids, uric acid and beta 2-microglobulin in man. | lld:pubmed |
| pubmed-article:6189503 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6189503 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6189503 | lld:pubmed |
